Filter
1099
Text search:
china
Featured
Recommendations
98
New Publications
173
Language
Document type
No document type
445
Studies & Reports
277
Guidelines
192
Manuals
62
Strategic & Response Plan
36
Fact sheets
35
Training Material
17
Situation Updates
14
Resource Platforms
7
Infographics
5
Brochures
4
Videos
3
Online Courses
2
Countries / Regions
Global
78
India
34
Brazil
32
Russia
25
South Africa
19
Myanmar / Burma
19
Western and Central Europe
19
Latin America and the Carribbean
18
China
17
South–East Asia Region
17
Syria
16
Nepal
14
Middle East and North Africa
14
Asia
14
Mozambique
13
Kenya
12
Africa
12
Indonesia
10
Ukraine
10
West and Central Africa
10
Venezuela
10
Ethiopia
9
Philippines
9
Colombia
9
East and Southern Africa
9
Eastern Europe
9
Nigeria
8
Uganda
8
Ecuador
8
Angola
8
Spain
8
Sierra Leone
7
Germany
7
Western Pacific Region
7
Liberia
6
Senegal
6
Tanzania
6
Malawi
6
Vietnam
6
Guinea
5
South Sudan
5
Thailand
5
Peru
5
Yemen
5
Portugal
5
Congo, Democratic Republic of
4
Guinea-Bissau
4
Ghana
4
Somalia
4
Cambodia
4
Bangladesh
4
Argentina
4
Eastern Europe and Central Asia
4
Paraguay
4
Haiti
3
Pakistan
3
Iraq
3
Rwanda
3
Malaysia
3
Madagascar
3
Chile
3
Jamaica
3
Japan
3
France
3
Morocco
2
USA
2
Cameroon
2
Zimbabwe
2
Afghanistan
2
Lebanon
2
Central African Republic
2
North Macedonia
2
Serbia
2
Bolivia
2
Lesotho
2
Italy
2
Tajikistan
2
Kyrgyzstan
2
Burkina Faso
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Jordan
1
Zambia
1
Turkey
1
Egypt
1
Singapore
1
Sudan
1
Benin
1
Namibia
1
Eswatini/ Swaziland
1
Hungary
1
Croatia
1
Honduras
1
El Salvador
1
Mexico
1
Sri Lanka
1
Other region
1
Mongolia
1
Laos
1
Congo-Brazzaville
1
Canada
1
Timor Leste/ East Timor
1
Iran
1
Uzbekistan
1
Australia
1
Georgia
1
Turkmenistan
1
Mauritius
1
United Kingdom
1
Norway
1
Azerbaijan
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
307
Clinical Guidelines
75
Public Health
52
Key Resources
41
Women & Child Health
34
Pharmacy & Technologies
11
Capacity Building
7
Annual Report MEDBOX
1
Toolboxes
COVID-19
258
Mental Health
96
HIV
91
TB
73
Planetary Health
68
Disability
49
AMR
36
Global Health Education
33
NTDs
32
NCDs
30
Health Financing Toolbox
27
Pharmacy
21
Rapid Response
19
Ebola & Marburg
15
Conflict
14
Refugee
14
Caregiver
12
Natural Hazards
10
Specific Hazards
9
2.0 Rapid Response
8
Polio
7
Malaria
7
Zika
5
Social Ethics
1
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
this publication serves as a practical guide and useful resource for practitioners, farmers, scientists, and technicians to better understand the initiative undertaken by GGGI. In this compendium, GGGI provides the latest knowledge and capacity building materials on these topics and offers informati
...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the
...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th
...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di
...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass
...
Background: In 2015, 5.3 million babies died in the third trimester of pregnancy and first month following birth. Progress in reducing neonatal mortality and stillbirth rates has lagged behind the substantial progress in reducing postneonatal and maternal mortality rates. The benefits to prenatal an
...
Policy Note #4: Myanmar Health Systems in Transition Policy Notes Series
Protecting people from financial hardship when they fall ill is one of the two key elements of universal health coverage (UHC). In practice, this means that the majority of health care costs have to be met from government ...
Protecting people from financial hardship when they fall ill is one of the two key elements of universal health coverage (UHC). In practice, this means that the majority of health care costs have to be met from government ...
Sectors in which Priority Adaptation Projects should be implemented first include:
- 1) Agriculture, Early Warning Systems and Forest (First Priority Level Sectors). This is followed by:
- 2) Public Health and Water Resources (Second Priority Level Sectors);
- 3) Coastal Zone (Thir ...
- 1) Agriculture, Early Warning Systems and Forest (First Priority Level Sectors). This is followed by:
- 2) Public Health and Water Resources (Second Priority Level Sectors);
- 3) Coastal Zone (Thir ...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
To support countries in adapting their response to different COVID-19 scenarios, the World Health Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing commissioned this scoping review of published and grey literature. The objective was to identify interventions
...
Rapport sur les populations clès
Accessed November 2017
PARTICIPANT GUIDE.
This Participant Guide has been designed to assist health facilities and community based non-clinicians to develop skills to provide linkage to care, adherence and retention in care services for chronic conditions
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
The publication is designed to provide Ipas staff, trainers, partners and other health-care providers with access to up-to-date, evidence-based recommendations. In general, the recommendations are the same as those in the World Health Organization’s 2012 Safe Abortion: Technical and Policy Guidanc
...
